These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10608113)

  • 21. Neural bases of pharmacological treatment of nicotine dependence - insights from functional brain imaging: a systematic review.
    Menossi HS; Goudriaan AE; de Azevedo-Marques Périco C; Nicastri S; de Andrade AG; D'Elia G; Li CS; Castaldelli-Maia JM
    CNS Drugs; 2013 Nov; 27(11):921-41. PubMed ID: 23853032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion.
    Cryan JF; Gasparini F; van Heeke G; Markou A
    Drug Discov Today; 2003 Nov; 8(22):1025-34. PubMed ID: 14690633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostics and therapy of nicotine dependence].
    Tuunainen A; Rimón R
    Duodecim; 1999; 115(3):296-302. PubMed ID: 11830876
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications.
    D'Souza MS
    Prog Brain Res; 2016; 223():191-214. PubMed ID: 26806777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nicotine replacement therapy and smoking cessation: what choice for its status?].
    Lagrue G
    Bull Acad Natl Med; 1999; 183(6):1175-82; discussion 1182-7. PubMed ID: 10560171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG.
    Beaver JD; Long CJ; Cole DM; Durcan MJ; Bannon LC; Mishra RG; Matthews PM
    Neuropsychopharmacology; 2011 Aug; 36(9):1792-800. PubMed ID: 21544072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tobacco smoking and nicotine dependence: biological basis for pharmacotherapy from nicotine to treatments that prevent relapse.
    Gold MS; Herkov MJ
    J Addict Dis; 1998; 17(1):7-21. PubMed ID: 9549599
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuropeptide systems and new treatments for nicotine addiction.
    Bruijnzeel AW
    Psychopharmacology (Berl); 2017 May; 234(9-10):1419-1437. PubMed ID: 28028605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of nicotine replacement therapy to treat nicotine withdrawal syndrome and aid temporary abstinence.
    Foulds J
    Int J Clin Pract; 2010 Feb; 64(3):292-4. PubMed ID: 20456168
    [No Abstract]   [Full Text] [Related]  

  • 31. Beliefs and reality of e-cigarette smoking.
    Menakuru S; Inzamam Ali M
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30279252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat.
    Paterson NE; Semenova S; Markou A
    Psychopharmacology (Berl); 2008 Jun; 198(3):351-62. PubMed ID: 18438738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nicotine replacement therapy].
    Handa S
    Nihon Rinsho; 2013 Mar; 71(3):482-6. PubMed ID: 23631240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nicotine dependence and psychiatric disorders.
    Salín-Pascual RJ; Alcocer-Castillejos NV; Alejo-Galarza G
    Rev Invest Clin; 2003; 55(6):677-93. PubMed ID: 15011738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.
    Weinberger AH; Sacco KA; Creeden CL; Vessicchio JC; Jatlow PI; George TP
    Schizophr Res; 2007 Mar; 91(1-3):217-25. PubMed ID: 17293085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in bupropion findings is not due to differences in measurement: comment on Teneggi et al.
    Shiffman S
    Psychopharmacology (Berl); 2006 Apr; 185(3):400-1. PubMed ID: 16482480
    [No Abstract]   [Full Text] [Related]  

  • 38. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
    Yuan M; Malagon AM; Yasuda D; Belluzzi JD; Leslie FM; Zaveri NT
    Behav Brain Res; 2017 Aug; 333():251-257. PubMed ID: 28693859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy of tobacco dependence.
    Talwar A; Jain M; Vijayan VK
    Med Clin North Am; 2004 Nov; 88(6):1517-34. PubMed ID: 15464111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zyban: a new aid to smoking cessation treatment--will it work for psychiatric patients?
    Farnam CR
    J Psychosoc Nurs Ment Health Serv; 1999 Feb; 37(2):36-42; quiz 43-4. PubMed ID: 10023606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.